Ann: PTX data demonstrates key OmniCAR features in next gen CAR-T, page-67

I find it strange the T-cell therapy enhancements (which are being kept silent - we know nothing about) are further progressed according to the timeline than the Omni-car program which we are receiving lots of new data/ information about.

One would think this is relevant information which shareholders should be informed of, as to exactly what are/is the T-cell therapy enhancement program.

I might start my own asx listed company and have 3 products (many shots on goal) label them groundbreaking and then tell shareholders i cant reveal what they are.....

Just a thought.

GO PTX!